Skip to content

Clinical efficacy and safety evaluation of herbal fumigation combined with acupoint application in the prevention and treatment of postoperative complications of severe prolapsed hemorrhoids

Clinical efficacy and safety evaluation of herbal fumigation combined with acupoint application in the prevention and treatment of postoperative complications of severe prolapsed hemorrhoids

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069778
Enrollment
Unknown
Registered
2023-03-24
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemorrhoids

Interventions

Treatment group:herbal fumigation + acupoint application
Control group:herbal fumigation + placebo application

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Patients meeting the diagnostic criteria of ?-? degree mixed hemorrhoids; ? 18-65 years old; ? Complete informed consent and relevant notification.

Exclusion criteria

Exclusion criteria: ? Combined with other anorectal diseases (tumors, polyps, anal fistula, anal fissure, etc.); ? Pregnant women; ? Previous anal surgery or trauma history; ? Accompanied with psychosis, diabetes, severe cardiovascular and cerebrovascular diseases, gastrointestinal diseases, severe allergies, coagulation dysfunction, etc; ? Suffering from infectious diseases such as AIDS, syphilis, tuberculosis, and malignant tumors.

Design outcomes

Primary

MeasureTime frame
Pain score;

Secondary

MeasureTime frame
Edema score;Bleeding score;Urinary retention score;Anal function score;Healing time;

Countries

CHINA

Contacts

Public ContactLU LIN YUAN

Shanghai Sixth People's Hospital

lly0526@sina.com18930174668

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026